Oxidative Medicine and Cellular Longevity

Volume 2014 (2014), Article ID 673959, 8 pages

http://dx.doi.org/10.1155/2014/673959

Research Article

Leucocyte Telomere Shortening in relation to Newly Diagnosed Type 2 Diabetic Patients with Depression

Zhelong Liu,¹ Jianhua Zhang,¹ Jiangtao Yan,² Yuping Wang,¹ and Yongsheng Li³

¹Division of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Avenue 1095, Wuhan 430030, China

²Division of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Avenue 1095, Wuhan 430030, China

³Division of Emergency Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China

Received 14 February 2014; Accepted 9 April 2014; Published 29 April 2014

Academic Editor: Si Jin

Copyright © 2014 Zhelong Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

The goal of this study is to investigate the association between oxidative stress and telomere length shortening in the comorbid depression and diabetes. Therefore, 71 patients with newly diagnosed type 2 diabetes (T2D) and 52 subjects with normal glycemic level (control, Ctrl) were enrolled. Depressive status was identified with the Depression Subscale of Hospital Anxiety and Depression Scale (HADS-D). Leukocyte telomere length ratio (T/S ratio) was determined with quantitative PCR. Oxidative stress status was evaluated with 8-hydroxy-desoxyguanosine (8-OHdG) assay kit. Some other biochemical blood testing was also performed. The data showed that T2D patients had higher proportion of depression evaluated by the HADS-D (, ). T/S ratio was significantly negatively correlated with 8-OHdG, HADS-D, age, HbA1c, FPG, and HOMA-IR. In addition, HADS-D was significantly positively correlated with HbA1c, FPG, HOMA-IR, and 8-OHdG. Both HADS-D and 8-OHdG were the major independent predictors for T/S ratio. This study indicates that oxidative stress contributes to both telomere length shortening and depression development in newly diagnosed type 2 diabetic patients, while in depression status, some other mechanisms besides oxidative stress may also affect the telomere length.

1. Introduction

Telomeres are tandem repeats of DNA sequence, TTAGGG at the end of eukaryotic chromosomes [1]. The important function of telomere is to protect the genomic DNA from being degenerating and maintain the genomic stability [2]. The telomere decreases with repeated cell division. When the shortened length gets to some exact extent, the cell develops to senescence. Oxidative stress is considered to be tightly related to the procedure of telomere decrease as it can induce the strand breaks of telomeric DNA [3, 4].

Recently increasing evidence showed the association between the shortening of leucocyte telomere length and several age-related diseases, including type 2 diabetes [5–7]. Type 2 diabetes (T2D), characterized with the clinical chronic hyperglycemia and insulin resistance, is nowadays one of the most threatening problems to the global public health. Although it has not been fully comprehended, more and more evidence shows that both oxidative stress and cell premature senescence may take an important part in the mechanism of T2D [5]. Some previous studies including our work suggested a probable relationship between oxidative stress and the leucocyte telomere length shortening in diabetic patients [8, 9].

The association of psychological stress and illness with telomere length change has also been reported lately [10, 11]. Depression, one of the most common forms of psychological disorders, often cooccurs with type 2 diabetes [12]. Diabetic patients with depression have higher HbA1c levels and poorer glycemic control [13]. They may have less physical exercises and be less compliant to take healthy diet and antidiabetic regimen [14]. What is more, it is verified that diabetic patients with depression have higher mortality rates due to myocardial infarction [15] and a latest systematic review shows that depression is associated with almost 1.5-fold increase risk of mortality in people with diabetes [16]. However, the mechanism of the combination and linkage of depression and diabetes is still unknown.

Although the telomere length decrease is identified in diabetic or depressive patients, respectively, there is no research work reported in the population of cooccurring depression and diabetes till now. Therefore, the aim of our study was to investigate the association between oxidative stress and telomere length shortening in the comorbid depression and diabetes.

2. Research Design and Methods

2.1. Patients and Controls

A total of 71 patients with newly diagnosed type 2 diabetes (T2D) (male 40/female 31) were recruited from the Division of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China, between January 2011 and June 2012. The subjects were questioned about their medical history and family history. The enrolled subjects were diagnosed with T2D no more than 1 month and had not received any antidiabetic agents yet. The diagnosis of diabetes was in accordance with World Health Organization criteria (fasting plasma glucose ≥ 7 mmol/L or 2-hour plasma glucose ≥ 11.1 mmol/L) [17]. 52 subjects with normal glycemic level were enrolled in control group (Ctrl group) (male 30/female 22). The individuals with pregnancy, acute inflammation, communicable diseases, cancer, stroke, severe cardiovascular disease, Alzheimer’s disease, dementia, or severe cognitive disorders were excluded. In this study, the definition of drinkers was those who consumed liquor within the last 30 days and the average pure alcohol intake ≥10 g per week. This study was carried out in accordance with the principle of Helsinki Declaration and approved by the local ethical committee. All participants gave written informed consent to participate in this study.

2.2. Assessment of Anthropometric Data

All subjects took physical examination by a physician. Blood pressure was measured in the sitting position after resting for 10 min. Waist circumference was measured midway between the lowest rib and the iliac crest in the upright standing position. Hip circumference was measured at the greater trochanter.

2.3. Assessment of Depression

For screening of depression, we used the Depression Subscale of Hospital Anxiety and Depression Scale (HADS-D), which consists of 7 questions [18]. All the subjects completed the HADS-D separately, without any interaction with research staff. Depression was identified as the score ≥10.

2.4. Blood Samples Collection and Laboratory Measurement

Participants were fasted overnight for 10 hours and had blood samples drawn from an antecubital vein, then immediately aliquoted into cryotubes as plasma, buffy coat, and red blood cells. Fasting plasma glucose (FPG) was measured using glucose oxidase method (AVE 2852 half auto biochemical analyzer), fasting insulin (FIN) was measured using electrochemiluminescence assay (Elecsys 2010, Roche Instrument Center AG), and HbA1c was measured using high pressure liquid chromatography (variant II, Bio-Rad). Peripheral insulin resistance was estimated by homeostasis model assessment (HOMA-IR = FIN FPG/22.5). Serum total cholesterol (TC), triacylglycerols (TG), high-density lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) levels were measured using enzymatic method performed on clinical chemistry analyzer (Roche/Hitachi MODULAR analyzer).

2.4.1. Measurement of Relative Telomere Length

All buffy-coat cryotubes were stored in freezers at −80°C. Genomic DNA was extracted from peripheral white blood cells using the QG-Mini80 workflow with DB-S kit (Fujifilm Corporation, Tokyo, Japan) as instructed.

Telomere length ratio (T/S ration) was measured using a quantitative PCR-based technique [19]. In this method, the ratio of the telomere repeat copy number (T) and single-copy gene number (S) was compared for each sample. Reactions for DNA samples were run in 7 L reaction volumes with ABI-7900 HT real-time thermal cycler (Applied Biosystems).

The primers are as follows.

 Telomere-F 5′-CGGTTTGTTTGGGTTTGGGTTTGGGTTTGGGTTTGGGTT-3′. Telomere-R 5′-GGCTTGCCTTACCCTTACCCTTACCCTTACCCTTACCCT-3′. -globin-F 5′-GCTTCTGACACAACTGTGTTCACTAGC-3′. -globin-R 5′-CACCAACTTCATCCACGTTCACC-3′. -globin-P FTGCATCTGACTCCTGAGGP.

Cycling conditions of telomere were as follows: 95°C incubation for 10 minutes followed by 35 cycles of 95°C for 15 seconds and 56°C for 1 min. As for the cycling conditions of -globin, 95°C incubation for 10 minutes followed by 40 cycles of 95°C for 15 sec and 56°C for 1 min. The specificity of all of the amplification was determined by melting curve analysis.

2.4.2. Measurement of 8-OHdG

8-OHdG in leucocyte DNA was quantified with OxiSelect oxidative DNA damage ELISA kit (Cell Biolab, Inc, San Diego, USA), which can be used to evaluate the degree of antioxidant stress [9].

2.5. Statistical Analysis

Analyses were performed with the SPSS 11.5 (SPSS) statistical package. Significance was defined as the value was less than 0.05. All variables were tested for normal distribution of the data. Data are shown as means ± standard deviation (SD) in a normal distribution, while as median with interquartile range (IQR, 25th~75th percentile) in a nonnormal distribution. Continuous variables differences between two groups were analyzed with Student’s test and among multiple groups with ANOVA and for nonparametric data with the Mann-Whitney U test or Kruskal-Wallis H test, respectively. A chi-square test was utilized for categorical data. To evaluate the reliability of the questionnaire of HADS-D, the internal consistency was used, which was examined with the Cronbach’s alpha, and the results >0.7 were judged as adequate. The Spearman correlation analysis was adopted to evaluate the correlation between telomere length and other factors including age, body mass index, waist circumference, waist-to-hip ratio, systolic and diastolic blood pressure, fasting plasma glucose, fasting insulin, HOMA-IR, HbA1c, lipids, 8-OHdG, and HADS-D. The correlation between HADS-D/8-OHdG and other factors was also examined in this way. Stepwise multiple linear regression was applied to determine independent predictors of T/S ratio in T2D group. Candidates for the stepwise multiple regressions were variables that yielded a value of less than 0.15 in the univariate analysis. Then collinear variables were excluded when the Spearman’s rank correlation coefficient was more than 0.7. The value was no less than 0.10 for variables entered the regression.

3. Result

3.1. Main Clinical and Biological Parameters in Subjects

Subjects with and without T2D did not differ significantly in terms of the proportion of smokers, drinkers, and the use of aspirin, statin, and antihypertension drugs. The subjects in T2D group were significantly older than in the control group. The sex ratio was similar in the two groups.

The values of BMI, waist circumference, WHR, the values of systolic blood pressure, diastolic blood pressure, HbA1c, FPG, HOMA-IR, TC, TG, and 8-OHdG were higher in the patients with T2D, while the HDL level was lower in the T2D group. The T/S ratio in the T2D group was significantly shorter than in the control group (Table 1).

Table 1: Demographic, clinical, and biochemical parameters of the study subjects of T2D and Ctrl.

T2D

Ctrl

Age (yrs)

0.028

Male [( (%)]
40 (56.34)
30 (57.69)
0.881

Current smokers [( (%)]
21 (29.58)
14 (26.92)
0.784

Current drinkers [( (%)]
13 (18.31)
8 (15.38)
0.670

Use of aspirin [( (%)]
8 (11.27)
4 (7.69)
0.509

Use of statin [( (%)]
7 (9.86)
4 (7.69)
0.677

Use of antihypertensive drugs[( (%)]
6 (8.45)
5 (9.62)
0.823

HADS-D score (point)*
8 (6, 9)
8 (6, 9)
0.200

HADS-D ≥ 10 [( (%)]
17 (23.9)
5 (9.6)
0.041

BMI (kg/m²)

0.000

Waist circumstance (cm)
87.5 (81.8, 94.0)
82.0 (78.0, 86.0)
0.000

WHR
0.84 (0.77, 0.89)
0.80 (0.74, 0.84)
0.000

Systolic blood pressure (mmHg)
132 (120, 141)
127 (123, 130)
0.040

Diastolic blood pressure (mmHg)
81 (75, 88)
74 (68, 80)
0.000

HbA1c (%)
8.29 (7.58, 8.90)
5.10 (4.80, 5.40)
0.000

FPG (mmol/L)

0.000

FIN (mIU/L)
11.44 (6.99, 13.29)
12.22 (7.8, 14.32)
0.520

HOMA-IR
4.51 (2.73, 5.54)
2.93 (2.00, 3.29)
0.000

Total cholesterol (mmol/L)

0.000

Triglyceride (mmol/L)
1.86 (1.12, 2.31)
1.20 (0.86, 1.32)
0.000

HDL-cholesterol (mmol/L)

0.020

LDL-cholesterol (mmol/L)

0.050

8-OHdG (ng/mL)

0.000

T/S ratio

0.000

Data are means ± SD, (%), or median (interquartile range).

T2D: type 2 diabetic group, Ctrl: control group, HADS-D: Depression Subscale of Hospital Anxiety and Depression Scale, BMI: body mass index, WHR: waist-to-hip ratio, FPG: fasting plasma glucose, FIN: fasting insulin, HOMA-IR: homeostasis model assessment-insulin resistance HOMA-IR = FIN (mIU/L) × FPG (mmol/L)/22.5, 8-OHdG: Human 8-hydroxy-desoxyguanosine.

*The total score of HADS-D is 21 and depression was identified as the score ≥10.

T2D group was further divided into two subgroups as with depression [T2D(D+)] and without depression (T2D(D−)); similarly, Ctrl groups also were subclassified as Ctrl(D+) and Ctrl(D−). Among the four subgroups, no significant difference was found in the indexes of age, proportion of male, smokers, drinkers, drugs used, SBP, FIN, HDL, and LDL. Comparing with the T2D(D−) patients, the T2D(D+) ones had higher HADS-D scores and T/S ratio with similar level of BMI, WHR, SBP, DBP, HbA1c, FPG, HOMA-IR, lipids, and 8-OHdG. Comparing with Ctrl(D+) patients, the T2D(D+) ones had higher proportion of hypotensive drugs and higher level of HbA1c, FPG, and TC. No remarkable difference was found in T/S, HOMA-IR, and 8-OHdG. Comparing with the Ctrl(D−) subjects, the Ctrl(D+) ones had higher BMI besides HADS-D scores. The Ctrl(D−) also showed lower level of telomere length (Table 2).

Table 2: Demographic, clinical, and biochemical parameters of the study subjects of subgroups with/without depression in T2Da and Ctrlb groups.

T2D
Ctrl

D+
D−
D+
D−

Age (yrs)

1.823
0.147

Male [((%)]
10 (58.82)
24 (44.44)
3 (50.00)
19 (41.30)
—
0.656

Current smokers [((%)]
5 (29.41)
16 (29.63)
2 (33.33)
12 (26.09)
—
0.971

Current drinkers [((%)]
2 (11.76)
11 (20.37)
1 (16.67)
7 (15.22)
—
0.834

Use of aspirin [((%)]
1 (5.88)
7 (12.96)
0 (0.00)
4 (8.70)
—
0.653

Use of statin [((%)]
3 (17.65)
4 (7.41)
1 (16.67)
3 (6.52)
—
0.474

Use of antihypertensive drugs [((%)]
3 (17.64)#
3 (5.56)#
0 (0.00)
5 (10.87)
—
0.00

HADS-D (point)
12 (10, 12)*⊙
7 (6, 8)#
12 (10, 12)*
7 (6, 8)
—
0.000

BMI (kg/m²)

5.033
0.003

Waist circumstance (cm)
87 (80, 91)*
88 (82, 94)*
81 (77, 87)
82 (78, 86)
—
0.000

WHR
0.82

(0.74, 0.88)
0.85

(0.79, 0.90)*
0.82

(0.75, 0.86)
0.80

(0.74, 0.84)
—
0.006

Systolic blood pressure (mmHg)
134 (120, 141)
131 (120, 141)
128 (123, 130)
126 (123, 130)
—
0.171

Diastolic blood pressure (mmHg)
79 (70, 84)
82 (75, 89)*
78 (72, 85)
74 (68, 131)
—
0.004

HbA1c (%)
8.4 (8, 9.1)*#
8.2 (7.5, 8.7)*#
5.3 (5.2, 5.5)
5.1 (4.7, 5.4)
—
0.000

FPG (mmol/L)

101.427
0.000

FIN (mIU/L)
12.55

(6.69, 15.02)
11.09

(6.99, 13.19)
12.95

(9.57, 16.40)
12.00

(7.74, 13.23)
—
0.617

HOMA-IR
5.54

(3.24, 6.25)*
4.19

(2.58, 5.02)*
3.09

(2.26, 3.70)
2.91

(2.00, 3.23)
—
0.000

Total cholesterol (mmol/L)

6.821
0.000

Triglyceride (mmol/L)

HDL-cholesterol (mmol/L)
1.89

(1.34, 1.88)*
1.91

(1.08, 2.36)*
1.74

(1.18, 2.13)
1.23

(0.85, 1.55)
—
0.001

1.841
0.143

LDL-cholesterol (mmol/L)

1.458
0.229

8-OHdG (ng/mL)

15.722
0.000

T/S ratio
1.70

(1.36, 2.06)*⊙
2.11

(1.82, 2.42)*
2.01

(1.91, 2.13)*
2.32

  (2.14, 2.47)
—
0.000

Data are means ± SD, (%), or median (interquartile range).

T2D: type 2 diabetic group, Ctrl: control group, HADS-D: Depression Subscale of Hospital Anxiety and Depression Scale, BMI: body mass index, WHR: waist-to-hip ratio, FPG: fasting plasma glucose, FIN: fasting insulin, HOMA-IR: homeostasis model assessment-insulin resistance HOMA - IR = FIN (mIU/L) × FPG (mmol/L)/22.5, 8-OHdG: Human 8-Hydroxy-desoxyguanosine.

asubgroup with/without depression in T2D is shown as T2D(D+)/T2D(D−), respectively,

bsubgroup with/without depression in Ctrl group is shown as Ctrl(D+)/Ctrl(D−), respectively.

for T2D(D+)/T2D(D−)/Ctrl(D+) versus Ctrl(D−).

for T2D(D+)/T2D(D−) versus Ctrl(D+).

for T2D(D+) versus T2D(D−).

3.2. HADS-D Evaluation with Internal Consistency

The chi-square test showed that the T2D patients had higher proportion of depression than control subjects, evaluated by the HADS-D (, ) (Table 1). The internal consistency of the HADS-D, as calculated by Cronbach’s , was valued as 0.716 in T2D group and 0.730 in Ctrl group, respectively.

3.3. Correlation between T/S Ratio and Other Factors in Whole Population

The correlation between T/S ratio and other factors was analyzed in the whole population of the two groups (). It was shown that age (, ), HADS-D (, ), HbA1c (, ), FPG (, ), HOMA-IR (, ), 8-OHdG (, ), SBP ( ), DBP (, ), and TG (, ) were significantly negatively correlated with T/S ratio, while FIN, age, BMI, wrist circumference, WHR, TC, TG, and LDL had no significant correlation with T/S ratio. This indicates that the decrease of telomere correlates with depression and oxidative stress besides aging, blood glucose level, and insulin resistance (Figure 1).

(a)

(b)

(c)

Figure 1: Correlation between T/S ratio and 8-OHdG(a), HADS-D (b), and age (c) in the whole population studied.

3.4. Correlation between HADS-D and Other Factors in Whole Population

It was shown that HbA1c (, ), FPG (, ), HOMA-IR (, ), 8-OHdG (, ), and age (, ) were significantly positively correlated with HADS-D, while other indexes had no significant correlation with HADS-D. These results suggested that depression related to hyperglycemia and insulin resistance besides telomere length shortening (as shown in Section 3.3).

3.5. Correlation between 8-OHdG and Other Factors in Whole Population

It was shown that HbA1c (, ), FPG (, ), HOMA-IR (, ), age (, ), BMI (, ), wrist circumference (, ), WHR (, ), DBP (, ), TC (, ), and TG (, ) were significantly positively correlated with 8-OHdG, while other indexes had no significant correlation with 8-OHdG. Thereby, oxidative stress relates to telomere length shortening, depression (as shown in Sections 3.2 and 3.3), aging, and insulin resistance with obesity.

3.6. Multiple Linear Regression Analysis in T2D Group

Stepwise multiple linear regression in T2D subjects was applied to evaluate independent predictors of T/S ratio. The results showed that both HADS-D and 8-OHdG were the major independent predictors of T/S ratio (, 0.001, resp.), thereby indicating that the type 2 diabetic patients with higher scores of HADS-D and in more severe oxidative stress status may have much more shortened telomere length. Other independent predictors included HbA1c, FPG, age, and SBP (Table 3).

Table 3: Predictors of leukocyte telomere length in type 2 diabetic patients.

Univariate analysis
Multiple linear regression

Unstandardized

coefficient (b)

Unstandardized

coefficient (b)

(95% confidence interval for b)

Age
−0.027
0.000
−0.012

(−0.019, −0.005)
0.002

BMI
0.011
0.683

Waist circumference
−0.006
0.390

WHR
0.074
0.920

SBP
−0.005
0.138
−0.006

(−0.010, −0.003)
0.001

DBP
−0.002
0.748

FPG
−0.204
0.000
−0.062

(−0.115, −0.009)
0.023

HbA1c
−0.287
0.000
−0.157

(−0.224, −0.090)
0.000

FIN
−0.003
0.744

HOMA-IR
−0.026
0.135
0.016

(−0.003, 0.035)
0.097

Total cholesterol
−0.014
0.823

Triglyceride
−0.041
0.473

HDL
0.28
0.242

LDL
−0.071
0.326

HADS-D
−0.115
0.000
−0.057

(−0.080, −0.033)
0.000

8-OHdG
−0.599
0.000
−0.238

(−0.369, −0.103)
0.001

4. Discussion

The result showed that oxidative stress could play an important role in the mechanism of telomere length shortening. Reactive oxygen species may induce deoxyguanosine conversion to 8-OHdG in the cellular nucleus, which is then released into blood [20]. Therefore, 8-OHdG was utilized as an indicator related to oxidative stress and remarkable negative correlation between 8-OHdG and T/S ratio was observed in the whole population studied, which is consistent with the previous findings [9]. On another side, compared with the diabetic subjects without depression, the diabetic patients with depression had higher level of 8-OHdG in this study. To our knowledge, it is the first time to evaluate the correlation between oxidative stress and depression with the detecting of blood 8-OHdG level and examining of HADS-D score. Furthermore, in both the diabetic and control subjects, the depressive ones had remarkable shorter telomere length than those free of depression, also indicating the relevance between depression and telomere degeneration. Up to now, it is the first time to show the interrelationship of oxidative stress and depression and telomere shortening in type 2 diabetic patients.

Interestingly, in diabetic group, the depressive ones had shorter telomere than those without depression, while their glycemia and 8-OHdG were in similar levels. That may be explained with the bias due to the small sample size in our study. Otherwise, there is the possibility that the depressive status might be more prone to induce telomere shortening throughout another mechanism rather than oxidative stress. Therefore, more studies must be made to answer this confusing question.

Insulin resistance is reported to be in relation to telomere length as the HOMA-IR and BMI are the important indexes for insulin resistance [21–23]. In our study, the T/S ratio is shown to be correlated with HOMA-IR but not with BMI in the whole population studied. In multiple linear regression analysis in T2D group, we failed to identify HOMA-IR to be independent predictor of T/S ratio as the 95% confidence interval for unstandardized coefficient is −0.003, 0.035 and the value is 0.097. This may also be attributed to the small sample size of this study.

The development of depression may be related to many factors. Aged females are reported with higher risk of depression [24, 25]. Life styles such as smoking and drinking and some drugs including aspirin, statins, and antihypertension agents are also indicated to affect the development of depression [26–30]. As for this study, the levels of the sex ratio, age, and the proportion of smokers, drinkers, and the drugs used mentioned above in the depression subgroups between T2D and Ctrl were shown to be similar. Additionally, the duration of diabetes, the insulin injection, and the level of hyperglycemic control may also correlate with depression [16, 31]. For this reason, only patients of newly diagnosed diabetes were included, who had never received any antihyperglycemic treatment.

In this study, the status of depression was evaluated with the HADS-D. This scale was initially designed to identify depression in clinical psychiatric hospitals, yet it has also been adopted to screen depression in nonhospitalized population and considered to be accurate and convenient [32, 33]. It is a 7-item self-report questionnaire and each item is scored 0 to 3 and a total score of 8 or greater indicates the presence of depression. However it was reported that the best accuracy was achieved with cutoff of 10 points in total [32]. The internal consistency of HADS-D was assessed with Cronbach’s alpha coefficient, which was 0.716 for T2D group and 0.730 for Ctrl group. It is regarded as satisfactory since the value of Cronbach’s alpha is over 0.7 [18].

There are still some limitations in this study. Firstly, this is a cross-sectional study and the sample size was small. So we should draw the conclusion very carefully and prospective studies with large sample size are needed to verify the findings. Secondly, although only the newly diagnosed patients were enrolled in this study, the hyperglycemic status without obvious diabetic symptoms might exist earlier before the diabetes was diagnosed [34]; therefore the latent hyperglycemia and oxidative stress could take effect on telomere length for some time. There may be discrepancy of the duration in the diabetic subjects and it is hard to be evaluated. Thirdly, the chronic diabetic complications including diabetic nephropathy, retinopathy, and neuropathy have not been evaluated in this study yet, which might indicate the long duration of diabetes. Fourthly, there are still some other factors that can affect the development of depression which are not evaluated in this study, such as economic income and social status [35, 36].

5. Conclusion

In summary, this study indicated that oxidative stress contributes to both telomere length shortening and depression development in newly diagnosed type 2 diabetic patients. What is more, in depression status some other mechanisms besides oxidative stress may also affect the telomere length. To fully elucidate the complicated interactions of diabetes and depression with oxidative stress and cell senility, more research work is needed in the future.

Abbreviations

T2D: | Type 2 diabetes
Ctrl: | Control group
T/S ratio: | Telomere length ratio
8-OHdG: | Human 8-hydroxy-desoxyguanosine
HADS-D: | The Depression Subscale of Hospital Anxiety and Depression Scale
HOMA-IR: | Homeostasis model assessment-insulin resistance
ROS: | Reactive oxygen species
FPG: | Fasting plasma glucose
FIN: | Fasting insulin
TC: | Total cholesterol
TG: | Triacylglycerols
HDL-C: | High-density lipoprotein cholesterol
LDL-C: | Low-density lipoprotein cholesterol
BMI: | Body mass index
WHR: | Waist-to-hip ratio.

Conflict of Interests

The authors declare that they have no conflict of interests.

Acknowledgments

The authors thank all their colleagues working in the Department of Internal Medicine, Tongji Medical College, Huazhong University of Science and Technology. This work was supported in part by Grants from National Nature Science Foundation of China (no. 81070190), Nature Science Foundation of Hubei province (no. 2009CDB049 and no. 2011CDB207), and the Fundamental Research Funds for the Central Universities (HUST 2012QN190).

References

D. Kejariwal, K. M. Stepien, T. Smith, H. Kennedy, D. A. Hughes, and M. J. Sampson, “Lack of association of colonic epithelium telomere length and oxidative DNA damage in Type 2 diabetes under good metabolic control,” BMC Endocrine Disorders, vol. 8, article 12, 2008.

E. H. Blackburn, “Switching and signaling at the telomere,” Cell, vol. 106, no. 6, pp. 661–673, 2001.

C. Autexier and N. F. Lue, “The structure and function of telomerase reverse transcriptase,” Annual Review of Biochemistry, vol. 75, pp. 493–517, 2006.

S. Makpol, A. Z. Abidin, K. Sairin, M. Mazlan, G. M. Top, and W. Z. W. Ngah, “γ-tocotrienol prevents oxidative stress-induced telomere shortening in human fibroblasts derived from different aged individuals,” Oxidative Medicine and Cellular Longevity, vol. 3, no. 1, pp. 35–43, 2010.

M. J. Sampson, M. S. Winterbone, J. C. Hughes, N. Dozio, and D. A. Hughes, “Monocyte telomere shortening and oxidative DNA damage in type 2 diabetes,” Diabetes Care, vol. 29, no. 2, pp. 283–289, 2006.

Q. Shen, X. Zhao, L. Yu et al., “Association of leukocyte telomere length with type 2 diabetes in mainland Chinese populations,” Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 4, pp. 1371–1374, 2012.

O. Uziel, J. A. Singer, V. Danicek et al., “Telomere dynamics in arteries and mononuclear cells of diabetic patients, effect of diabetes and of glycemic control,” Experimental Gerontology, vol. 42, no. 10, pp. 971–978, 2007.

K. D. Salpea, P. J. Talmud, J. A. Cooper et al., “Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation,” Atherosclerosis, vol. 209, no. 1, pp. 42–50, 2010.

D. Ma, W. Zhu, S. Hu, X. Yu, and Y. Yang, “Association between oxidative stress and telomere length in Type 1 and Type 2 diabetic patients,” Journal of Endocrinological Investigation, vol. 36, pp. 1032–1037, 2013.

E. S. Epel, E. H. Blackburn, J. Lin et al., “Accelerated telomere shortening in response to life stress,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 49, pp. 17312–17315, 2004.

J. H. Kim, H. K. Kim, J. H. Ko, H. Bang, and D. C. Lee, “The relationship between leukocyte mitochondrial DNA copy number and telomere length in community-dwelling elderly women,” PLoS ONE, vol. 8, Article ID e67227, 2013.

S. Ali, M. A. Stone, J. L. Peters, M. J. Davies, and K. Khunti, “The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis,” Diabetic Medicine, vol. 23, no. 11, pp. 1165–1173, 2006.

P. J. Lustman and R. E. Clouse, “Depression in diabetic patients: the relationship between mood and glycemic control,” Journal of Diabetes and its Complications, vol. 19, no. 2, pp. 113–122, 2005.

L. E. Egede, “Effect of depression on self-management behaviors and health outcomes in adults with type 2 diabetes,” Current Diabetes Reviews, vol. 1, no. 3, pp. 235–243, 2005.

J. F. Scherrer, L. D. Garfield, T. Chrusciel et al., “Increased risk of myocardial infarction in depressed patients with type 2 diabetes,” Diabetes Care, vol. 34, no. 8, pp. 1729–1734, 2011.

F. E. van Dooren, G. Nefs, M. T. Schram, F. R. Verhey, J. Denollet, and F. Pouwer, “Depression and risk of mortality in people with diabetes mellitus, a systematic review and meta-analysis,” PLoS ONE, vol. 8, Article ID e57058, 2013.

K. G. Albertiand and P. Z. Zimmet, “Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1, diagnosis and classification of diabetes mellitus provisional report of a WHO consultation,” Diabetic Medicine, vol. 15, pp. 539–553, 1998.

M. M. Iversen, G. S. Tell, T. Riise et al., “History of foot ulcer increases mortality among individuals with diabetes: ten-year follow-up of the Nord-Trondelag health study, Norway,” Diabetes Care, vol. 32, no. 12, pp. 2193–2199, 2009.

Z. Yang, X. Huang, H. Jiang et al., “Short telomeres and prognosis of hypertension in a Chinese population,” Hypertension, vol. 53, no. 4, pp. 639–645, 2009.

N. Tentolouris, R. Nzietchueng, V. Cattan et al., “White blood cells telomere length is shorter in males with type 2 diabetes and microalbuminuria,” Diabetes Care, vol. 30, no. 11, pp. 2909–2915, 2007.

J. P. Gardner, S. Li, S. R. Srinivasan et al., “Rise in insulin resistance is associated with escalated telomere attrition,” Circulation, vol. 111, no. 17, pp. 2171–2177, 2005.

S. Demissie, D. Levy, E. J. Benjamin et al., “Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study,” Aging Cell, vol. 5, no. 4, pp. 325–330, 2006.

O. S. Al-Attas, N. M. Al-Daghri, M. S. Alokail et al., “Adiposity and insulin resistance correlate with telomere length in middle-aged Arabs: the influence of circulating adiponectin,” European Journal of Endocrinology, vol. 163, no. 4, pp. 601–607, 2010.

F. Cardin, F. Ambrosio, P. Amodio, et al., “Quality of life and depression in a cohort of female patients with chronic disease,” BMC Surgery, vol. 12, supplement 1, p. S10, 2012.

V. K. Burt and K. Stein, “Epidemiology of depression throughout the female life cycle,” Journal of Clinical Psychiatry, vol. 63, no. 7, pp. 9–15, 2002.

P. Sun, J. B. Unger, Q. Guo et al., “Comorbidity between depression and smoking moderates the effect of a smoking prevention program among boys in China,” Nicotine and Tobacco Research, vol. 9, supplement 4, pp. S599–S609, 2007.

J. G. Rahola, “Somatic drugs for psychiatric diseases, aspirin or simvastatin for depression?” Current Neuropharmacology, vol. 10, pp. 139–158, 2012.

F. P. Thorndike, R. Wernicke, M. Y. Pearlman, and D. A. F. Haaga, “Nicotine dependence, PTSD symptoms, and depression proneness among male and female smokers,” Addictive Behaviors, vol. 31, no. 2, pp. 223–231, 2006.

M. Workman and J. Beer, “Depression, suicide ideation, and aggression among high school students whose parents are divorced and use alcohol at home,” Psychological Reports, vol. 70, no. 2, pp. 503–511, 1992.

I. Lesser, H. Myers, K.-M. Lin, and E. M. Simonsick, “Letter to the editor,” Psychosomatic Medicine, vol. 58, no. 5, pp. 515–516, 1996.

G. Nefs, V. J. Pop, J. Denollet, and F. Pouwer, “The longitudinal association between depressive symptoms and initiation of insulin therapy in people with type 2 diabetes in primary care,” PLoS ONE, vol. 8, Article ID e78865, 2013.

A. Falavigna, O. Righesso, A. R. Teles, et al., “Depression Subscale of the Hospital Anxiety and Depression Scale applied preoperatively in spinal surgery,” Arquivos de Neuro-Psiquiatria, vol. 70, pp. 352–356, 2012.

B. Andrews, J. Hejdenberg, and J. Wilding, “Student anxiety and depression: comparison of questionnaire and interview assessments,” Journal of Affective Disorders, vol. 95, no. 1–3, pp. 29–34, 2006.

“Screening for type 2 diabetes,” Diabetes Care, vol. 23, supplement 1, pp. S20–S23, 2000.

J. Hong, M. Knapp, and A. Mcguire, “Income-related inequalities in the prevalence of depression and suicidal behaviour: a 10-year trend following economic crisis,” World Psychiatry, vol. 10, no. 1, pp. 40–44, 2011.

T. Leone, E. Coast, S. Narayanan, and A. de Graft Aikins, “Diabetes and depression comorbidity and socio-economic status in low and middle income countries (LMICs): a mapping of the evidence,” Global Health, vol. 8, p. 39, 2012.